Skip to content
Search

Latest Stories

Omega Pharmacy in Derbyshire sold in just 18 days

Even pharmacies with relatively low dispensing numbers remain in demand, says Carl Steer at Christie & Co

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.


Situated on St Thomas Road, just two miles south of Derby, the community pharmacy dispenses around 3,000 items per month.

It is positioned opposite a large modern medical centre in a densely populated residential area.

An online clinic and prescription service based in the East Midlands has acquired the pharmacy in a notably fast transaction.

“From offer to completion, this sale took just 18 working days which is not only my fastest ever sale in 20 years with Christie & Co, but is also four to six months quicker than a typical sale and we achieved over the guide price,” said Carl Steer, director of pharmacy at Christie & Co.

He shared that the pharmacy attracted strong interest from first-time buyers, distance-selling contractors, and existing pharmacy operators since marketing commenced.

“This shows that even if you have a pharmacy withquite low dispensing numbers, the market is active and it will be a perfect buy for someone,” he added.

The broker has also completed the sale of two additional pharmacies this week—LG Pharmacy in Glasgow, Scotland, and Clarkes Pharmacy in County Armagh, Northern Ireland.

LG Pharmacy in Glasgow, sold to GNA Healthcare through Christie and CoLG PharmacyChristie & Co

LG Pharmacy, owned by Michael and Lisa Christie since 2006, was brought to market as the couple sought a well-earned retirement.

It has been acquired by Gazenfer Ali of GNA Healthcare, a group operator with three other pharmacies in Glasgow and one in Fife.

Clarkes Pharmacy in County Armagh, a key acquisition by a first-time buyerClarkes PharmacyChristie & Co

Clarkes Pharmacy, the only pharmacy in County Armagh village, was owned by Aidan Hughes for the past 20 years. He brought it to market to allow him to retire.

The pharmacy has been purchased by Paul McGimpsey, a first-time buyer from the Armagh area.

Karl Clezy at Christie & Co noted an increasing presence of first-time buyers in Northern Ireland, with another sale to a first-time buyer in Belfast soon to be completed.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less